ROSEMARIE FORONDA: Open Payments
NPI 1154346914 · WAILUKU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,272 in 37 payments from 11 companies in 2025. Trend: 2023 $8,433 · 2024 $1,088 · 2025 $1,272
Food & beverage: $1,230Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $322 |
| Mannkind Corporation | 6 | $171 |
| Dexcom, Inc. | 1 | $156 |
| Terumo Medical Corporation | 1 | $125 |
| Boston Scientific Corporation | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $108 |
| Lilly USA, LLC | 5 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Averitas Pharma Inc. | 1 | $18 |
Products named: Ozempic, AFREZZA, DEXCOM G7 GSS (161), General - Atherectomy, JARDIANCE, MOUNJARO, Kerendia, Wegovy.
Industry payments across HI — which companies pay providers there.
